As the rise of GLP-1 weight-loss drugs begins to reshape not just waistlines, but the wider food economy, what started as a breakthrough treatment for obesity and diabetes is rapidly becoming a commoditised lifestyle trend, with implications stretching from supermarket shelves to British farmland.
AF Chief Agricultural Officer John Barrett considers how changing consumer attitudes towards health, nutrition and appetite could reshape food purchasing habits, influence demand for different crops and livestock systems, and potentially drive a transition from a food economy focused on cheap calories towards one centred on protein, nutritional value and sustainability.
The pharmaceutical trend reshaping the food economy